Boehringer Ingelheim, a leading pharmaceutical firm, has transferred of manufacturing operations of one of its innovative medicines for the treatment of type 2 diabetes to Alpha Pharma in Saudi Arabia.
Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, announced on Thursday (Feb 8) the transfer of manufacturing operations of one of its innovative medicines for the treatment of type 2 diabetes to Alpha Pharma in Saudi Arabia.